Alexion Pharma (ALXN) Beats Q1 EPS Views by 8c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development: 179.31M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) reported Q1 EPS of $0.59, $0.08 better than the analyst estimate of $0.51. Revenue for the quarter came in at $166.1 million versus the consensus estimate of $165.86 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- Traws Pharma (TRAW) Tops Q2 EPS by 27c
- Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
